GenmabGenmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.
Suggest an EditGenmab Information, Including Revenue, Investors, Funding, Competitors & Key Metrics
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. Its discovery, development, and manufacturing teams are using cutting-edge technology to create and develop products to address unmet medical needs.
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. Its discovery, development, and manufacturing teams are using cutting-edge technology to create and develop products to address unmet medical needs.
Company Highlights
Employees
Total Investment Amt
MoM Headcount GrowthYoY Headcount Growth
Year Founded
1999
Employees2,602
Location (HQ)
DNK
Since Last Funding
14 years 4 months
Monthly Website Visitors
65.5K
Total Investment Amt$200M
Last Funding Round
Post Ipo Equity
MoM Headcount Growth0.27%
YoY Headcount Growth15.08%
Key Metrics
Senior Hires
| Name | Linkedin Profile | Position | Date Joined |
|---|---|---|---|
| John Doe | https://www.linkedin.com/in/johndoe | CEO | CEO |
| Jane Doe | https://www.linkedin.com/in/janedoe | CTO | CTO |
| John Smith | https://www.linkedin.com/in/johnsmith | CFO | CFO |
| Jane Smith | https://www.linkedin.com/in/janesmith | COO | COO |
Similar Companies
- AVATAMEDGenerate BiomedicinesGennao BioMythic TherapeuticsIGM BiosciencesCytomX TherapeuticsCogent BiosciencesApexigenMOMA TherapeuticsSAB BiotherapeuticsAdimabGigaGenRenBioMabPlex InternationalApoGen BiotechnologiesGO TherapeuticsGrid TherapeuticsIbex BiosciencesRevMAb BiosciencesY-mAbs TherapeuticsMeditope BiosciencesX BODYProvenance BiopharmaceuticalsMammogenRondo TherapeuticsZymeworksNGM BiopharmaceuticalsAnaptysBioCrescendo BiologicsCapella BioScienceOxford BioTherapeuticsMabVax TherapeuticsMemgenOncoQuestMestag TherapeuticsImmune BiosolutionsMedannex LtdKymabAffomix CorporationMerusarGEN-XMemo TherapeuticsNumabGenenta ScienceAgomAb TherapeuticsVectorYFab'entechGamaMabs PharmaMablink BioscienceCellmAbsCovagenKenta BiotechSeagenHumanigenCelldex TherapeuticsImmunoGenXOMAAmgenMerrimack PharmaceuticalsNascent BiotechMacroGenicsTranscentaBeiGeneBerGenBioAbzenaAlphamab OncologyI-Mab BiopharmaAdageneAblynxSynbio TechnologiesOncoResponse, Inc.Hansa BiopharmaBiocytogenEpimAb BiotherapeuticsGmax BiopharmFutureGenGenFleet TherapeuticsMolcureLyvgen Biopharma4-Antibody AGTrinomabAltruBioInfinimmuneAprogenIngenia Therapeutics Inc.SymphogenRoche GlycartPharmAbcineRinat NeuroscienceGamida Cell Ltd.MedarexImmunomedicsTradewind BioScienceMacromoltek Inc.Chimeron BioGV20 TherapeuticsOptieum BiotechnologiesGigaMuneNovAbSomru BioscienceLife Science Factory
Manufacturing
Health Care
Biotechnology Research